Latest Articles

Publication Date
Pharmacokinetic Relationship Between GLP-1s, Endometrial Cancer Cell Growth - DocWire News

Pharmacokinetic Relationship Between GLP-1s, Endometrial Cancer Cell Growth DocWire News

Published: Oct. 24, 2024, 2:55 p.m.
Episode 6: The Evolving Role of Radiation Therapy in Endometrial Cancer - Medscape

Episode 6: The Evolving Role of Radiation Therapy in Endometrial Cancer Medscape

Published: Oct. 24, 2024, 1:44 p.m.
Efficacy, Safety of Sacituzumab Govitecan in Patients With Advanced Solid Tumors (TROPiCS-03): Analysis in Patients With Advanced Endometrial Cancer - Medpage Today

Efficacy, Safety of Sacituzumab Govitecan in Patients With Advanced Solid Tumors (TROPiCS-03): Analysis in Patients With Advanced Endometrial Cancer Medpage Today

Published: Oct. 23, 2024, 2:47 p.m.
ASCO Reading Room | Alessandro Santin, MD, on a Promising ADC for Refractory Endometrial Cancer - Medpage Today

ASCO Reading Room | Alessandro Santin, MD, on a Promising ADC for Refractory Endometrial Cancer Medpage Today

Published: Oct. 23, 2024, 2:47 p.m.
New fresh look on vimentin's role in endometrial cancer - Universitetet i Bergen

New fresh look on vimentin's role in endometrial cancer Universitetet i Bergen

Published: Oct. 22, 2024, 2:31 p.m.
New fresh look on vimentin's role in endometrial cancer - uib.no

New fresh look on vimentin's role in endometrial cancer uib.no

Published: Oct. 22, 2024, 2:31 p.m.
Association of endometrial cancer risk with hypertension- an updated meta-analysis of observational studies - Nature.com

Association of endometrial cancer risk with hypertension- an updated meta-analysis of observational studies Nature.com

Published: Oct. 22, 2024, 2:08 p.m.
Pembrolizumab Aids Survival With High-Risk Endometrial Cancer - Physician's Weekly

Pembrolizumab Aids Survival With High-Risk Endometrial Cancer Physician's Weekly

Published: Oct. 22, 2024, 6:31 a.m.
A nomogram model to predict recurrence of early-onset endometrial cancer after resection based on clinical parameters and immunohistochemical markers: A multi-institutional study - Frontiers

A nomogram model to predict recurrence of early-onset endometrial cancer after resection based on clinical parameters and immunohistochemical markers: A multi-institutional study Frontiers

Published: Oct. 21, 2024, 6:48 p.m.
Pembrolizumab aids survival with high-risk endometrial cancer - Medical Xpress

Pembrolizumab aids survival with high-risk endometrial cancer Medical Xpress

Published: Oct. 21, 2024, 5:50 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!